Short Interest Reporting: A Reversal for DECISION DIAGNOSTICS (OTCMKTS:DECN) Is Near. The Stock Has Decrease in Shorts

December 1, 2016 - By kentuckypostne   ·   0 Comments

Short Interest Reporting: A Reversal for DECISION DIAGNOSTICS (OTCMKTS:DECN) Is Near. The Stock Has Decrease in Shorts

The stock of DECISION DIAGNOSTICS (OTCMKTS:DECN) registered a decrease of 85.15% in short interest. DECN’s total short interest was 1,500 shares in December as published by FINRA. Its down 85.15% from 10,100 shares, reported previously. The stock closed at $0.147 during the last session. It is down 70.59% since April 28, 2016 and is downtrending. It has underperformed by 76.51% the S&P500.

Decision Diagnostics Corp. is a distributor of prescription and non-prescription diagnostics and home testing products. The company has a market cap of $16.21 million. The Firm is a maker of the Genstrip 50 and GenUltimate! Glucose test strips, class II medical devices for at-home use for the measurement of glucose. It currently has negative earnings. It distributes several lines of ostomy, wound care and post-surgery medical products.

DECN Company Profile

Decision Diagnostics Corp., incorporated on March 2, 2001, is a distributor of prescription and non-prescription diagnostics and home testing products. The Firm is a maker of the Genstrip 50 and GenUltimate! Glucose test strips, class II medical devices for at-home use for the measurement of glucose. The Firm distributes several lines of ostomy, wound care and post-surgery medical products. It provides smart phone electronic medical record (EMR) applications to be used by physicians at the point of care. It provides information technology (IT) services in several medical care market channels by providing physicians with information at the point of care through the use of smart cell phones as the information delivery vehicle, which allow physicians to carry, access and update their patients’ histories, medication data and care guidelines.

More news for Decision Diagnostics Corp (OTCMKTS:DECN) were recently published by: Seekingalpha.com, which released: “Decision Diagnostics: Meaningfully Derisked And Substantially Undervalued” on June 07, 2016. Prnewswire.com‘s article titled: “Instacare Changes Name to Decision Diagnostics Corp.; Will Apply for Nasdaq Bx …” and published on December 01, 2011 is yet another important article.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By kentuckypostne


Readers Comments (0)





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>